Harrow, Inc. Common Stock (HROW) is a publicly traded Healthcare sector company. As of October 26, 2026, HROW trades at $28.63 with a market cap of $1.07B and a P/E ratio of -31.09. HROW moved +0.00% today. Year to date, HROW is -41.96%; over the trailing twelve months it is -27.15%. Its 52-week range spans $20.85 to $54.85. Analyst consensus is strong buy with an average price target of $64.33. Rallies surfaces HROW's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for HROW, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $28.63 |
| Market Cap | $1.07B |
| P/E Ratio | -31.09 |
| EPS | $-0.99 |
| Dividend Yield | 0.00% |
| 52-Week High | $54.85 |
| 52-Week Low | $20.85 |
| Volume | 6.33K |
| Avg Volume | 0 |
| Revenue (TTM) | $275.59M |
| Net Income | $-37.23M |
| Gross Margin | 73.28% |
8 analysts cover HROW: 0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $64.33.